<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Science business</title>
    <subTitle>the promise, the reality, and the future of biotech</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Pisano, Gary P.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="local">Print books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">mau</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Boston, Mass</placeTerm>
    </place>
    <publisher>Harvard Business School Press</publisher>
    <dateIssued>c2006</dateIssued>
    <dateIssued encoding="marc">2006</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xvi, 237 p. : ill. ; 25 cm.</extent>
  </physicalDescription>
  <tableOfContents>The science-based business : a novel experiment -- Mapping the scientific landscape -- The complex anatomy of drug R&amp;D -- Drug R&amp;D and the organizational challenges -- The anatomy of a science-based business -- The performance of the biotech industry : promise versus reality -- The monetization of intellectual property -- Organizational strategies and business models -- The path ahead.</tableOfContents>
  <tableOfContents>The science-based business : a novel experiment -- Mapping the scientific landscape -- The complex anatomy of drug R&amp;D -- The organizational challenges of drug R&amp;D -- The anatomy of a science-based business -- The performance of the biotech industry : promise versus reality -- The monetization of intellectual property -- Organizational strategies and business models -- The path ahead.</tableOfContents>
  <note type="statement of responsibility">Gary P. Pisano.</note>
  <note>Includes bibliographical references (p. 213-221) and index.</note>
  <subject authority="lcsh">
    <topic>Biotechnology industries</topic>
    <topic>History</topic>
  </subject>
  <classification authority="lcc">HD9999.B442 P57 2006</classification>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn">9781591398400</identifier>
  <identifier type="lccn">2006016541</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">DLC</recordContentSource>
    <recordCreationDate encoding="marc">060518</recordCreationDate>
    <recordChangeDate encoding="iso8601">20180710125754.0</recordChangeDate>
    <recordIdentifier source="US-DLC">14381208</recordIdentifier>
  </recordInfo>
</mods>
